AMP's automated IMA tube filling line receives commercial approval

NewsGuard 100/100 Score

Alliance Medical Products, Inc. ("AMP") announced today it has received commercial approval of its automated IMA tube filling line. The line will be put to use immediately for the commercial manufacture of a sterile ophthalmic ointment recently approved by the FDA.

“The IMA line has a capacity of 30,000 tubes per shift with tube size diameters ranging 10 to 60 mm with volumes ranging from 1 to 50 grams.”

"The approval of this drug and AMP's automated IMA tube filling line further solidifies our company's reputation as the industry's leading cGMP supplier of difficult to manufacture formulations," said Juan Valdes, President and CEO. "The IMA line has a capacity of 30,000 tubes per shift with tube size diameters ranging 10 to 60 mm with volumes ranging from 1 to 50 grams." The line will be used primarily to fill sterile gels, creams and ointments.

"AMP's innovative process design expertise was a key factor in achieving these approvals. These approvals open a new door for us, as we see nasal and otic drug products pushed into sterile filling along with ophthalmics which have long been packaged sterile," said Valdes.

SOURCE Alliance Medical Products, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.